DDX3X and hepatocellular carcinoma: On the other hand, the tumor suppressor role of DDX3X has been characterized: silencing of DDX3X expression in hepatocellular carcinoma HepG2 cells promoted chemoresistance to anti-cancer drugs doxorubicin and 5-fluorouracil [53].